Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta‐analysis

Overview of attention for article published in Diabetes, Obesity & Metabolism, December 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#26 of 6,132)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 47 news outlets
policy: 1 policy source
twitter: 127 X users

patent: 4 patents
facebook: 1 Facebook page
guideline: 2 clinical guideline sources

Readers on

mendeley: 239 Mendeley

So far, Altmetric has seen 137 X posts from 127 X users, with an upper bound of 1,521,370 followers.

@CortexIQ Metformin is not FDA approved for the treatment of prediabetes, and can only be prescribed off-label, so is not commonly done so. Metformin has poor compliance due to side effects like nausea. 30% of metformin doses were not taken by T2D pati…

Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta-analysis. https://t.co/FNN3eoDgrT Compared with metformin, adherence (%) was better for sulphonylureas and thiazolidinediones

RT @rincondesisifo: (Diabetes Obes Metab) Comparación de la adherencia al tto en pac con DM2 https://t.co/QXbtFUXWA1 Rev Sist y MA

(Diabetes Obes Metab) Comparación de la adherencia al tto en pac con DM2 https://t.co/QXbtFUXWA1 Rev Sist y MA

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 133 additional X posts.